Ytterbium-169: A promising new radionuclide for intravascular brachytherapy

Cardiovascular Radiation Medicine

Volumn 2, Issue 3, 2001, Pages 173-180

  Patel, Neil S ^a   Fan, Pei ^a   Chiu Tsao, Sou Tung ^a   Ravi, Kumar ^a   Sherman, Warren ^a   Quon, Harry ^a   Pisch, Julianna ^a   Tsao, Hung Sheng ^b   Harrison, Louis B ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b SUN MICROSYSTEMS   (United States)

Author keywords

Calcific plaques; Dose distribution; Gamma; Intravascular brachytherapy; Iodine 125; Iridium 192; Radionuclides; Stents; Ytterbium 169

Indexed keywords

CALCIUM; IODINE 125; IRIDIUM 192; RADIOISOTOPE; STEEL; WATER; YTTERBIUM;

ARTERY WALL; ARTICLE; BRACHYTHERAPY; CATHETER; DOSE RESPONSE; GAMMA RADIATION; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION PROTECTION; RADIATION SHIELD; STENT;

BRACHYTHERAPY; CATHETERIZATION; FEASIBILITY STUDIES; HUMANS; IODINE RADIOISOTOPES; IRIDIUM RADIOISOTOPES; MONTE CARLO METHOD; RADIOISOTOPES; RADIOTHERAPY DOSAGE; YTTERBIUM;

EID: 0035700759     PISSN: 15221865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-1865(01)00085-3     Document Type: Article

References (46)

1. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia
2. Restenosis after experimental angioplasy: Intimal, medial and adventitial changes associated with constrictive remodeling
3. Compensatory enlargement of human atherosclerotic coronary arteries
4. Identification of a potential role for adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries
5. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
6. Intracoronary gamma radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis
7. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 month
8. Progress in clinical trials for coronary arterial restenosis using beta radiation sources
9. Conformal external beam irradiation (EBI) of a stented coronary artery
10. External beam irradiation inhibits neointimal hyperplasia following balloon angioplasty
11. Effect of external beam irradiation on neointimal hyperplasia after experimental coronary artery injury
12. Dosimetric feasibility of conformal radiation therapy to prevent coronary restenosis after angioplasty
13. Comparability of the external vs. internal location of radiation in inhibiting neointimal hyperplasia
14. Interference effect of neighboring seeds on the dose distribution from a train of Ir-192 seeds
15. Beta particle and conversion electron effects on Ir-192 dosimetry in intravascular brachytherapy
16. Novel radioisotopes for intravascular brachytherapy
17. Catheter-based Pd-103 to inhibit restenosis. First experience in a pig coronary artery preparation
18. Effect of stent on radiation dosimetry in an in-stent restenosis model
19. Effect of calcium on dose distribution in intravascular brachytherapy
20. The American Brachytherapy Society perspective on intravascular brachytherapy
21. Review of endovascular brachytherapy physics for prevention of restenosis
22. On the depth of penetration of photons and electrons for intravascular brachytherapy
23. Implantation guidelines for Yb-169 seed interstitial treatments
24. Dosimety of Yb-169 seed model X1267
25. Dosimetric characteristics, air-kerma strength calibration and verification of monte carlo simulation for a new ytterbium-169 brachytherapy source
26. The potential of ytterbium 169 in brachytherapy: A brief physical and radiobiological assessment
27. A secondary air kerma strength standard for Yb-169 interstitial brachytherapy sources
28. A comparison of radial dose functions for Pd-103, I-125, Sm-145, Am-241, Yb-169, and Cs-137 brachytherapy sources
29. GafChromic film dosimetry for Yb-169 seeds
30. Yb-169 seed dose distribution using TLD
31. Analysis of the radiobiology of ytterbium-169 and iodine-125 permanent brachytherapy implants
32. First clinical application of a new brachytherapy source-ytterbium-169
33. Design guidelines for the selection and use of stainless steel
34. Tissue substitutes in experimental radiation physics
35. 192Ir seeds at distances close to the source
36. 192Ir using GAFChromic film
37. 192Ir source
38. Management of peripheral vascular disease: Innovative approaches using radiation therapy
39. Intracoronary radiation for prevention of restenosis
40. Irradiation and stenting
41. Radiobiological principles in intravascular irradiation
42. Theoretical assessment of dose-rate effect in endovascular brachytherapy